[ad_1]
The minister told LRT Radio on Thursday that he expected “favorable decisions from the European Medicines Agency regarding the vaccine in the next few days or hours” but acknowledged that European countries, including Lithuania, had received a “strong reputational blow. “by stopping vaccination. with the vaccine.
“For the time being, since our vaccination strategy and all logistics were based only on vaccinating priority groups, we will probably now reconsider this vaccine as well, maybe we will change those solutions and maybe allow vaccination only for those who want it. But the decisions Finals have not yet been taken here, “said A. Dulkys, when asked how he would try to restore the reputation of this vaccine.
According to him, with the influx of reports of vaccination interruptions from Europe, the reputation of this vaccine “has already been damaged and we should have addressed the issue one way or another.”
“I just want to reiterate that when countries like France, Germany, Spain, Italy are holding back, I can no longer imagine that the authority in Lithuania has an expert who can convince that skeptical person that AstraZeneca will be vaccinated,” he said.
“I think there was no good decision, there was a bad and worse decision,” Dulkys added.
Lithuania followed the lead of several other European Union countries by stopping the AstraZeneca coronavirus vaccination on Tuesday night, although both A. Dulkys and Prime Minister Ingrida Šimonytė said they were not preparing to do so.
Vaccination has been suspended until the European Medicines Agency issues final conclusions on the safety of the vaccine, the agency will address the issue on Thursday.
The decision was made on the recommendation of the State Drug Control Agency, which received three reports of blood clots that occurred after vaccination, but the agency says it has no evidence that the ailments were caused by the vaccine.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
